Characterizing Associations and SNP-Environment Interactions for GWAS-Identified Prostate Cancer Risk Markers—Results from BPC3
Year: 2011
Type: article
Study design: Observational Study
Abstract: Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNPs) associated with prostate cancer risk. However, whether these associations can be consistently replicated, vary with disease aggressiveness (tumor stage and grade) and/or interact with non-genetic potential risk factors or other SNPs is unknown. We therefore genotyped 39 SNPs from regions identified by several prostate cancer GWAS in 10,501 prostate cancer cases and 10,831 controls from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). We replicated 36 out of 39 SNPs (P-values ranging from 0.01 to 10⁻²⁸). Two SNPs located near KLK3 associated with PSA levels showed differential association with Gleason grade (rs2735839, P = 0.0001 and rs266849, P = 0.0004; case-only test), where the alleles associated with decreasing PSA levels were inversely associated with low-grade (as defined by Gleason grade < 8) tumors but positively associated with high-grade tumors. No other SNP showed differential associations according to disease stage or grade. We observed no effect modification by SNP for association with age at diagnosis, family history of prostate cancer, diabetes, BMI, height, smoking or alcohol intake. Moreover, we found no evidence of pair-wise SNP-SNP interactions. While these SNPs represent new independent risk factors for prostate cancer, we saw little evidence for effect modification by other SNPs or by the environmental factors examined.
Source: PLoS ONE
Authors: Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, Ruth C. Travis, Daniele Campa, Sonja I. Berndt, W. Ryan Diver, Gianluca Severi, Naomi Allen, Gerald Andriole, Bas Bueno-de-Mesquita, Stephen J. Chanock, David Crawford, J. Michael Gaziano, Graham G. Giles, Edward Giovannucci, Carolyn Guo, Christopher A. Haiman, Richard B. Hayes, Jytte Halkjaer, David J. Hunter, Mattias Johansson, Rudolf Kaaks, Laurence N. Kolonel, Carmen Navarro, Elio Riboli, Carlotta Sacerdote, Meir Stampfer, Daniel O. Stram, Michael J. Thun, Dimitrios Trichopoulos, Jarmo Virtamo, Stephanie J. Weinstein, Meredith Yeager, Brian Henderson, Jing Ma, Loic Le Marchand, Demetrius Albanes, Peter Kraft
Institutions: Harvard University, University of Southern California, Imperial College London, University of Oxford, German Cancer Research Center, National Institutes of Health, Division of Cancer Epidemiology and Genetics, American Cancer Society, The University of Melbourne, Cancer Council Victoria, Washington University in St. Louis, National Institute for Public Health and the Environment, University of Colorado Denver, Brigham and Women's Hospital, VA Boston Healthcare System, Monash University, NYU Langone Health, Danish Cancer Society, Centre international de recherche sur le cancer, Umeå University, University of Hawaiʻi at Mānoa, University of Hawaii System, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Italian institute for Genomic Medicine, Piedmont Reference Center for Epidemiology and Cancer Prevention, Finnish Institute for Health and Welfare
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Awards: G1420790711, G2919159421, Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3., Elucidating Loci Involved in Prostate Cancer Suceptibility, Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3, G4996234081, G5021959070, Physicians' Health Study II: Prevention Trial of Vitamins, Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3, Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3, G8013581208
OpenAlex ID: W1990239685
